Evidence mapPaperPMID 40890865Full record

ArticleBMC biomedical engineering2025

Diabetic retinopathy screening using machine learning: a systematic review.

Fitsum Mesfin Dejene, Taye Girma Debelee, Friedhelm Schwenker, Yehualashet Megersa Ayano, Degaga Wolde Feyisa

Abstract read
In one paragraph

Article in BMC biomedical engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fitsum Mesfin DejeneComputer Vision, Ethiopian Artificial Intelligence Institute, Addis Ababa, 40782, Ethiopia.ORCID http://orcid.org/0009-0005-1801-013X
Taye Girma DebeleeComputer Vision, Ethiopian Artificial Intelligence Institute, Addis Ababa, 40782, Ethiopia. taye.girma@aii.et.ORCID http://orcid.org/0000-0002-0876-2021
Friedhelm SchwenkerInstitute of Neural Information, University of Ulm, 89069, Ulm, Germany.ORCID http://orcid.org/0000-0001-5118-0812
Yehualashet Megersa AyanoComputer Vision, Ethiopian Artificial Intelligence Institute, Addis Ababa, 40782, Ethiopia.ORCID http://orcid.org/0000-0001-5591-2240
Degaga Wolde FeyisaComputer Vision, Ethiopian Artificial Intelligence Institute, Addis Ababa, 40782, Ethiopia.ORCID http://orcid.org/0000-0002-9887-881X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic retinopathy (DR) stands as a leading cause of global blindness. Early identification and prompt treatment are crucial in preventing vision impairment caused by diabetic retinopathy (DR). Manual screening of retinal fundus images is challenging and time-consuming. Additionally, there is a significant gap between the number of DR patients and the number of medical experts. Integrating machine learning (ML) and deep learning (DL) techniques is becoming a viable alternative to traditional DR screening techniques. However, the absence of a retinal dataset with standardized quality, the complexity of DL models, and the need for high computational resources are challenges. Therefore, in this study, we studied and analyzed the research landscape in integrating ML techniques in DR screening. In this regard, our work contributes significantly in several aspects. Initially, we identify and characterize images of the retinal fundus that are readily available. Then, we discuss commonly used preprocessing techniques in DR screening. In addition, we analyze the progress of ML techniques in DR screening. Lastly, we discussed existing challenges and showed future directions.

Indexed as

Computer visionDeep learningDiabetic retinopathy screeningMachine learningTransfer learning

Identifiers

PMID40890865
PMCPMC12403315

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.